{"pmid":32438345,"title":"Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer.","text":["Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer.","Most patients with thyroid nodules and thyroid cancer (TC) referred for diagnostic work-up and treatment are not considered at higher risk of infection from SARS-CoV-2 compared to the general population. On the other hand, healthcare resources should be spared to the maximum extent possible during a pandemic. Indeed, while thyroid nodules are very common, only a small percentage are cancerous and, in turn, most thyroid cancers are indolent in nature. Accordingly, diagnostic work-up of thyroid nodules, thyroid surgery for either benign or malignant thyroid nodules and radioiodine treatment for differentiated thyroid cancers may be safely postponed during SARS-CoV-2 pandemic. Appropriate patient counselling, however, is mandatory and red flags should be carefully identified prompting immediate evaluation and treatment as appropriate. For these selected cases diagnostic work-up (e.g. ultrasound, scintigraphy, fine-needle aspiration), surgery and radioiodine therapy may proceed despite the threat of SARS-CoV-2 infection and COVID-19, after an individual risk-benefit analysis.","Eur J Endocrinol","Vrachimis, Alexis","Iacovou, Ioannis","Giannoula, Evanthia","Giovanella, Luca","32438345"],"abstract":["Most patients with thyroid nodules and thyroid cancer (TC) referred for diagnostic work-up and treatment are not considered at higher risk of infection from SARS-CoV-2 compared to the general population. On the other hand, healthcare resources should be spared to the maximum extent possible during a pandemic. Indeed, while thyroid nodules are very common, only a small percentage are cancerous and, in turn, most thyroid cancers are indolent in nature. Accordingly, diagnostic work-up of thyroid nodules, thyroid surgery for either benign or malignant thyroid nodules and radioiodine treatment for differentiated thyroid cancers may be safely postponed during SARS-CoV-2 pandemic. Appropriate patient counselling, however, is mandatory and red flags should be carefully identified prompting immediate evaluation and treatment as appropriate. For these selected cases diagnostic work-up (e.g. ultrasound, scintigraphy, fine-needle aspiration), surgery and radioiodine therapy may proceed despite the threat of SARS-CoV-2 infection and COVID-19, after an individual risk-benefit analysis."],"journal":"Eur J Endocrinol","authors":["Vrachimis, Alexis","Iacovou, Ioannis","Giannoula, Evanthia","Giovanella, Luca"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438345","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1530/EJE-20-0269","e_drugs":["Iodine-131"],"topics":["Prevention"],"weight":1,"_version_":1667521393691983873,"score":9.490897,"similar":[{"pmid":32438340,"title":"Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism.","text":["Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism.","This manuscript provides guidance on the management of thyroid dysfunction during the COVID-19 pandemic. Auto-immune thyroid diseases are not linked to increased risks of COVID-19. Uncontrolled thyrotoxicosis may result in more severe complications from SARS-CoV-2 infection, including thyroid storm. The management of patients with a new diagnosis of hyperthyroidism is best undertaken with a block and replace regimen due to limited biochemical testing availability. Antithyroid drug (ATD)-induced neutropenia may favour the progression of COVID-19 and symptoms of infection may be confused with SARS-CoV-2 infection. The withdrawal of ATDs and urgent measurement of neutrophils should be considered in case of flu-like manifestations occurring in the initial months of treatment. Urgent surgery or 131-I may be undertaken in selected cases of uncontrolled thyrotoxicosis. Patients with COVID-19 infection may present with conjunctivitis, which could cause diagnostic difficulties in patients with new or existing Graves' ophthalmopathy. Patients who are on replacement treatment with thyroid hormones should ensure they have sufficient supply of medication. The usual advice to increase dosage of levothyroxine during pregnancy should be adhered to. Many newly presenting and previously diagnosed patients with thyroid dysfunction can be managed through virtual telephone or video clinics supported by a dedicated nurse-led service, depending on available facilities.","Eur J Endocrinol","Boelaert, Kristien","Visser, W Edward","Taylor, Peter Nicholas","Moran, Carla","Leger, Juliane","Persani, Luca","32438340"],"abstract":["This manuscript provides guidance on the management of thyroid dysfunction during the COVID-19 pandemic. Auto-immune thyroid diseases are not linked to increased risks of COVID-19. Uncontrolled thyrotoxicosis may result in more severe complications from SARS-CoV-2 infection, including thyroid storm. The management of patients with a new diagnosis of hyperthyroidism is best undertaken with a block and replace regimen due to limited biochemical testing availability. Antithyroid drug (ATD)-induced neutropenia may favour the progression of COVID-19 and symptoms of infection may be confused with SARS-CoV-2 infection. The withdrawal of ATDs and urgent measurement of neutrophils should be considered in case of flu-like manifestations occurring in the initial months of treatment. Urgent surgery or 131-I may be undertaken in selected cases of uncontrolled thyrotoxicosis. Patients with COVID-19 infection may present with conjunctivitis, which could cause diagnostic difficulties in patients with new or existing Graves' ophthalmopathy. Patients who are on replacement treatment with thyroid hormones should ensure they have sufficient supply of medication. The usual advice to increase dosage of levothyroxine during pregnancy should be adhered to. Many newly presenting and previously diagnosed patients with thyroid dysfunction can be managed through virtual telephone or video clinics supported by a dedicated nurse-led service, depending on available facilities."],"journal":"Eur J Endocrinol","authors":["Boelaert, Kristien","Visser, W Edward","Taylor, Peter Nicholas","Moran, Carla","Leger, Juliane","Persani, Luca"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438340","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1530/EJE-20-0445","locations":["Antithyroid","neutropenia"],"e_drugs":["Thyroxine"],"topics":["Prevention"],"weight":1,"_version_":1667521393592369153,"score":586.1083},{"pmid":32437031,"title":"Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.","text":["Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.","BACKGROUND: In the face of the COVID-19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons (ACS) issuing recommendations to postpone nonurgent surgeries. METHODS: An institutional multidisciplinary group of Head and Neck Surgical Oncology, Surgical Endocrinology, and Medical Endocrinology devised Surgical Triaging Guidelines for Endocrine Surgery during COVID-19, aligned with phases of care published by the ACS. RESULTS: Phases of care with examples of corresponding endocrine cases are outlined. Most cases can be safely postponed with active surveillance, including most differentiated and medullary thyroid cancers. During the most acute phase, all endocrine surgeries are deferred, except thyroid tumors requiring acute airway management. CONCLUSIONS: These guidelines provide context for endocrine surgery within the spectrum of surgical oncology, with the goal of optimal individualized multidisciplinary patient care and the expectation of significant resource diversion to care for patients with COVID-19.","Head Neck","Jozaghi, Yelda","Zafereo, Mark E","Perrier, Nancy D","Wang, Jennifer R","Grubbs, Elizabeth","Gross, Neil D","Fisher, Sarah","Sturgis, Erich M","Goepfert, Ryan P","Lai, Stephen Y","Best, Conor","Busaidy, Naifa L","Cabanillas, Maria E","Dadu, Ramona","Gagel, Robert F","Habra, Mouhammed A","Hu, Mimi I","Jimenez, Camilo","Sherman, Steven I","Thosani, Sonali","Varghese, Jeena","Waguespack, Steven G","Weitzman, Steven","Ying, Anita K","Graham, Paul H","32437031"],"abstract":["BACKGROUND: In the face of the COVID-19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons (ACS) issuing recommendations to postpone nonurgent surgeries. METHODS: An institutional multidisciplinary group of Head and Neck Surgical Oncology, Surgical Endocrinology, and Medical Endocrinology devised Surgical Triaging Guidelines for Endocrine Surgery during COVID-19, aligned with phases of care published by the ACS. RESULTS: Phases of care with examples of corresponding endocrine cases are outlined. Most cases can be safely postponed with active surveillance, including most differentiated and medullary thyroid cancers. During the most acute phase, all endocrine surgeries are deferred, except thyroid tumors requiring acute airway management. CONCLUSIONS: These guidelines provide context for endocrine surgery within the spectrum of surgical oncology, with the goal of optimal individualized multidisciplinary patient care and the expectation of significant resource diversion to care for patients with COVID-19."],"journal":"Head Neck","authors":["Jozaghi, Yelda","Zafereo, Mark E","Perrier, Nancy D","Wang, Jennifer R","Grubbs, Elizabeth","Gross, Neil D","Fisher, Sarah","Sturgis, Erich M","Goepfert, Ryan P","Lai, Stephen Y","Best, Conor","Busaidy, Naifa L","Cabanillas, Maria E","Dadu, Ramona","Gagel, Robert F","Habra, Mouhammed A","Hu, Mimi I","Jimenez, Camilo","Sherman, Steven I","Thosani, Sonali","Varghese, Jeena","Waguespack, Steven G","Weitzman, Steven","Ying, Anita K","Graham, Paul H"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437031","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26169","keywords":["covid","coronavirus","endocrine","guideline","surgery"],"locations":["optimal"],"topics":["Prevention"],"weight":1,"_version_":1667521393616486402,"score":471.9138},{"pmid":32312717,"title":"Cytology in the time of coronavirus disease (covid-19): an Italian perspective.","text":["Cytology in the time of coronavirus disease (covid-19): an Italian perspective.","INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed.","J Clin Pathol","Vigliar, Elena","Iaccarino, Antonino","Bruzzese, Dario","Malapelle, Umberto","Bellevicine, Claudio","Troncone, Giancarlo","32312717"],"abstract":["INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed."],"journal":"J Clin Pathol","authors":["Vigliar, Elena","Iaccarino, Antonino","Bruzzese, Dario","Malapelle, Umberto","Bellevicine, Claudio","Troncone, Giancarlo"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312717","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1136/jclinpath-2020-206614","keywords":["cytological techniques","health services","infection control","medical oncology","safety"],"locations":["Italian","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493468803074,"score":466.17972},{"pmid":32500518,"pmcid":"PMC7270156","title":"Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?","text":["Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?","The ongoing spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a significant threat to global health. As the coronavirus outbreak began spreading, hospitals were forced to relocate resources to treat the growing number of COVID-19 patients. As a consequence, doctors across the country canceled tens of thousands of nonurgent surgeries. However, recognizing that the COVID-19 situation may be highly variable and fluid in different communities across the country, elective surgery could be still allowed in some centers for patients included in the high-priority class. The majority of endocrine disorders requiring surgical treatment in patients identifiable as first-priority class, or needing hospitalization within 30 days, are generally represented by malignant thyroid tumors, hyperthyroidism, hyperparathyroidism, and some adrenal disorders. The need for urgent intervention is evaluated on a case-by-case basis according to the severity of the symptoms, the likelihood of progression, and global clinical judgment. On the basis of the above indications, during the last 4 weeks, we performed 18 planned surgical treatments in patients with thyroid cancer (total thyroidectomies, plus lymph node dissection if needed) or multinodular toxic goiter. In no case, postoperative ventilatory support was needed, and the average hospital stay was 3 days. The negative COVID-19 status for all the treated patients was appropriately evaluated beforehand. Nobody knows how long the current COVID-19 pandemic will be lasting. Certainly, we will be requested in the next future to incrementally offer surgical services for endocrine disorders that have been deferred for the COVID-19 pandemic.","Endocrine","Lombardi, Celestino Pio","D'Amore, Annamaria","Grani, Giorgio","Ramundo, Valeria","Boscherini, Mauro","Gordini, Luca","Marzi, Federica","Tedesco, Silvia","Bocale, Raffaella","32500518"],"abstract":["The ongoing spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a significant threat to global health. As the coronavirus outbreak began spreading, hospitals were forced to relocate resources to treat the growing number of COVID-19 patients. As a consequence, doctors across the country canceled tens of thousands of nonurgent surgeries. However, recognizing that the COVID-19 situation may be highly variable and fluid in different communities across the country, elective surgery could be still allowed in some centers for patients included in the high-priority class. The majority of endocrine disorders requiring surgical treatment in patients identifiable as first-priority class, or needing hospitalization within 30 days, are generally represented by malignant thyroid tumors, hyperthyroidism, hyperparathyroidism, and some adrenal disorders. The need for urgent intervention is evaluated on a case-by-case basis according to the severity of the symptoms, the likelihood of progression, and global clinical judgment. On the basis of the above indications, during the last 4 weeks, we performed 18 planned surgical treatments in patients with thyroid cancer (total thyroidectomies, plus lymph node dissection if needed) or multinodular toxic goiter. In no case, postoperative ventilatory support was needed, and the average hospital stay was 3 days. The negative COVID-19 status for all the treated patients was appropriately evaluated beforehand. Nobody knows how long the current COVID-19 pandemic will be lasting. Certainly, we will be requested in the next future to incrementally offer surgical services for endocrine disorders that have been deferred for the COVID-19 pandemic."],"journal":"Endocrine","authors":["Lombardi, Celestino Pio","D'Amore, Annamaria","Grani, Giorgio","Ramundo, Valeria","Boscherini, Mauro","Gordini, Luca","Marzi, Federica","Tedesco, Silvia","Bocale, Raffaella"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500518","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s12020-020-02357-7","keywords":["covid-19","endocrine emergencies","endocrine surgery","thyroid cancer"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1668890966443950080,"score":431.38113},{"pmid":32436948,"title":"Subacute thyroiditis after SARS-CoV-2 infection.","text":["Subacute thyroiditis after SARS-CoV-2 infection.","CONTEXT: Subacute thyroiditis (SAT) is a thyroid disease of viral or post-viral origin. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly worldwide and Italy has been severely affected by this outbreak. OBJECTIVES: To report the first case of SAT related to SARS-CoV-2 infection. METHODS: We describe the clinical, laboratory and imaging features of a 18 year old woman who came to our attention for fever, neck pain radiated to the jaw and palpitations occurring 15 days after a SARS-CoV-2 positive oropharyngeal swab. Coronavirus disease 2019 (COVID-19) had been mild and the patients had completely recovered in few days. RESULTS: At physical examination the patient presented with an increased heart rate and a painful and enlarged thyroid on palpation. At laboratory exams FT4 and FT3 were high, TSH undetectable and inflammatory markers and white blood cell count elevated. Bilateral and diffuse hypoechoic areas were detected at neck ultrasound. One month earlier, thyroid function and imaging were both normal. We diagnosed SAT and the patient started prednisone. Neck pain and fever recovered within two days and the remaining symptoms within one week. Thyroid function and inflammatory markers normalized in 40 days. CONCLUSIONS: We report the first case of SAT after a SARS-CoV-2 infection. We alert clinicians to additional and unreported clinical manifestations associated with COVID-19.","J Clin Endocrinol Metab","Brancatella, Alessandro","Ricci, Debora","Viola, Nicola","Sgro, Daniele","Santini, Ferruccio","Latrofa, Francesco","32436948"],"abstract":["CONTEXT: Subacute thyroiditis (SAT) is a thyroid disease of viral or post-viral origin. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly worldwide and Italy has been severely affected by this outbreak. OBJECTIVES: To report the first case of SAT related to SARS-CoV-2 infection. METHODS: We describe the clinical, laboratory and imaging features of a 18 year old woman who came to our attention for fever, neck pain radiated to the jaw and palpitations occurring 15 days after a SARS-CoV-2 positive oropharyngeal swab. Coronavirus disease 2019 (COVID-19) had been mild and the patients had completely recovered in few days. RESULTS: At physical examination the patient presented with an increased heart rate and a painful and enlarged thyroid on palpation. At laboratory exams FT4 and FT3 were high, TSH undetectable and inflammatory markers and white blood cell count elevated. Bilateral and diffuse hypoechoic areas were detected at neck ultrasound. One month earlier, thyroid function and imaging were both normal. We diagnosed SAT and the patient started prednisone. Neck pain and fever recovered within two days and the remaining symptoms within one week. Thyroid function and inflammatory markers normalized in 40 days. CONCLUSIONS: We report the first case of SAT after a SARS-CoV-2 infection. We alert clinicians to additional and unreported clinical manifestations associated with COVID-19."],"journal":"J Clin Endocrinol Metab","authors":["Brancatella, Alessandro","Ricci, Debora","Viola, Nicola","Sgro, Daniele","Santini, Ferruccio","Latrofa, Francesco"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436948","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1210/clinem/dgaa276","keywords":["covid-19","sars-cov-2","coronavirus","subacute thyroiditis","thyroid","virus"],"locations":["Wuhan","China","Italy","Thyroid"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"e_drugs":["Prednisone"],"topics":["Case Report"],"weight":1,"_version_":1667521393611243520,"score":408.41135}]}